Pharmacological profiling of disulfiram using human tumor cell lines and human tumor cells from patients.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Biochemical Pharmacology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/J.BCP.2006.08.016PMID 17026967
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Screening of an annotated compound library for drug activity in a resistant myeloma cell line

  2006cited by this paper
• Inhibition of proteasome activity, nuclear factor-KappaB translocation and cell survival by the antialcoholism drug disulfiram.

  2006cited by this paper
• Inhibition of proteasome activity, nuclear factor‐KB translocation and cell survival by the antialcoholism drug disulfiram

  2006cited by this paper
• Activated type I TGFβ receptor kinase enhances the survival of mammary epithelial cells and accelerates tumor progression

  2006cited by this paper
• Identification of molecular mechanisms for cellular drug resistance by combining drug activity and gene expression profiles

  2005cited by this paper
• Inhibition of prostate cancer cellular proteasome activity by a pyrrolidine dithiocarbamate-copper complex is associated with suppression of proliferation and induction of apoptosis.

  2005cited by this paper
• Clioquinol and pyrrolidine dithiocarbamate complex with copper to form proteasome inhibitors and apoptosis inducers in human breast cancer cells

  2005cited by this paper
• Oncogenic Ras in tumour progression and metastasis

  2005cited by this paper
• Activated type I TGFbeta receptor (Alk5) kinase confers enhanced survival to mammary epithelial cells and accelerates mammary tumor progression

  2005cited by this paper
• The role of glutathione in cancer

  2004cited by this paper
• Disulfiram inhibits activating transcription factor/cyclic AMP-responsive element binding protein and human melanoma growth in a metal-dependent manner in vitro, in mice and in a patient with metastatic disease.

  2004cited by this paper
• Disulfiram facilitates intracellular Cu uptake and induces apoptosis in human melanoma cells.

  2004cited by this paper
• Multiparametric evaluation of apoptosis: effects of standard cytotoxic agents and the cyanoguanidine CHS 828.

  2004cited by this paper
• The proteasome: a suitable antineoplastic target

  2004cited by this paper
• Disulfiram‐mediated inhibition of NF‐κB activity enhances cytotoxicity of 5‐fluorouracil in human colorectal cancer cell lines

  2003cited by this paper
• Cu/Zn Superoxide Dismutase Plays Important Role in Immune Response1

  2003cited by this paper
• On and off: proteasome and TGF-β signaling

  2003cited by this paper
• Inhibition of invasion and angiogenesis by zinc-chelating agent disulfiram.

  2003cited by this paper
• On and off: proteasome and TGF-beta signaling.

  2003cited by this paper
• Metallothionein: the multipurpose protein

  2002cited by this paper
• Disulfiram induces apoptosis in human melanoma cells: a redox-related process.

  2002cited by this paper
• Disulfiram is a potent in vitro inhibitor of DNA topoisomerases.

  2001cited by this paper
• Biphasic effects of dithiocarbamates on the activity of nuclear factor-kappaB.

  2000cited by this paper
• Biphasic effects of dithiocarbamates on the activity of nuclear factor-κB

  2000cited by this paper
• Novel biphasic effect of pyrrolidine dithiocarbamate on neuronal cell viability is mediated by the differential regulation of intracellular zinc and copper ion levels, NF‐κb, and MAP kinases

  2000cited by this paper
• Relationship between diagnosis-specific activity of cytotoxic drugs in fresh human tumour cells ex vivo and in the clinic.

  1999cited by this paper
• Aberrant responses of human lymphocytic neoplasms to cytokine regulation

  1998cited by this paper
• Induction of apoptosis by thiuramdisulfides, the reactive metabolites of dithiocarbamates, through coordinative modulation of NFκB c‐fos/c‐jun, and p53 proteins

  1998cited by this paper
• Disulfiram is a potent inhibitor of proteases of the caspase family.

  1997cited by this paper
• Anti-cancer drug characterisation using a human cell line panel representing defined types of drug resistance.

  1996cited by this paper
• Some practical considerations and applications of the national cancer institute in vitro anticancer drug discovery screen

  1995cited by this paper
• Cytotoxic drug sensitivity testing of tumor cells from patients with ovarian carcinoma using the fluorometric microculture cytotoxicity assay (FMCA).

  1994cited by this paper
• Distinct effects of glutathione disulphide on the nuclear transcription factor kappa B and the activator protein-1.

  1994cited by this paper
• Laboratory determination of chemotherapeutic drug resistance in tumor cells from patients with leukemia, using a fluorometric microculture cytotoxicity assay (FMCA)

  1992cited by this paper
• Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells

  1992cited by this paper
• Feasibility of the fluorometric microculture cytotoxicity assay (FMCA) for cytotoxic drug sensitivity testing of tumor cells from patients with acute lymphoblastic leukemia.

  1992cited by this paper
• Cytotoxicity of diethyldithiocarbamate in human versus rodent cell lines

  1990cited by this paper
• Chemotherapeutic drug sensitivity testing of human leukemia cells in vitro using a semiautomated fluorometric assay.

  1990cited by this paper
• Radioactive and nonradioactive methods for the in vivo determination of disulfiram, diethyldithiocarbamate, and diethyldithiocarbamate-methyl ester.

  1978cited by this paper

• Emerging nanodelivery systems for cuproptosis induction: design strategies and multidimensional regulatory mechanisms.

  2026cites this paper
• Repurposing disulfiram for ALDH-positive NSCLC: Network-based inhibition of EGFR, COX-2, and MAPK1.

  2026cites this paper
• Advances in drug-releasing vaginal rings

  2026cites this paper
• Disulfiram activates autophagy via proteasome inhibition and c-Fos/beclin-1 upregulation, synergizing with chloroquine

  2025cites this paper
• Reactivating Hippo by drug compounds to suppress gastric cancer and enhance chemotherapy sensitivity

  2024cites this paper
• Disulfiram/Copper induces Bak-mediated caspase-independent apoptosis in MCF-7 cells.

  2024cites this paper
• The immunomodulatory function and antitumor effect of disulfiram: paving the way for novel cancer therapeutics

  2023cites this paper
• A disulfiram/copper gluconate co-loaded bi-layered long-term drug delivery system for intraperitoneal treatment of peritoneal carcinomatosis.

  2023cites this paper
• Preparation and Characterisation of Zinc Diethyldithiocarbamate–Cyclodextrin Inclusion Complexes for Potential Lung Cancer Treatment

  2023cites this paper
• Disulfiram ameliorates bleomycin induced pulmonary inflammation and fibrosis in rats

  2023cites this paper
• Co-delivery of a tumor microenvironment-responsive disulfiram prodrug and CuO2 nanoparticles for efficient cancer treatment

  2023cites this paper
• Advancing Cancer Therapy with Copper/Disulfiram Nanomedicines and Drug Delivery Systems

  2023cites this paper
• Repurposing approved non-oncology drugs for cancer therapy: a comprehensive review of mechanisms, efficacy, and clinical prospects

  2023cites this paper
• Disulfiram/copper induces antitumor activity against gastric cancer cells in vitro and in vivo by inhibiting S6K1 and c-Myc

  2022cites this paper
• Repurposing Disulfiram as an Antimicrobial Agent in Topical Infections

  2022cites this paper
• Disulfiram in glioma: Literature review of drug repurposing

  2022cites this paper
• Formamidine-Based Thiuram Disulfides as Efficient Inhibitors of Acid Corrosion of Mild Steel: Electrochemical, Surface, and Density Functional Theory/Monte Carlo Simulation Studies

  2022cites this paper
• Mechanism of zinc ejection by disulfiram in nonstructural protein 5A.

  2021cites this paper
• Overcoming therapeutic resistance in glioblastoma: Moving beyond the sole targeting of the glioma cells

  2021cites this paper
• The Effect of Disulfiram in the Prevention of Postoperative Adhesion Formation in an Experimental Rat Uterine Horn Model

  2021cites this paper
• The combination of disulfiram and copper for cancer treatment.

  2020cites this paper
• Designing precision medicine panels for drug refractory cancers targeting cancer STEMNESS traits.

  2020cites this paper
• Disulfiram/cytarabine eradicates a subset of acute myeloid leukemia stem cells with high aldehyde dehydrogenase expression.

  2020cites this paper
• Disulfiram/copper markedly induced myeloma cell apoptosis through activation of JNK and intrinsic and extrinsic apoptosis pathways.

  2020cites this paper
• In silico drug repositioning based on drug-miRNA associations

  2020cites this paper
• Formamidine-based thiuram disulfides: Synthesis, structural characterization, biological studies, and preliminary cheminformatics evaluation

  2020cites this paper
• Anti-tumor activity and mitochondrial stability of disulfiram in HL-60 cells

  2019cites this paper
• Repurposing Disulfiram as an Anti-Cancer Agent: Updated Review on Literature and Patents.

  2019cites this paper
• ALDH2 Repression Promotes Lung Tumor Progression via Accumulated Acetaldehyde and DNA Damage

  2019cites this paper
• The Combination of Metformin and Disulfiram-Cu for Effective Radiosensitization on Glioblastoma Cells

  2019cites this paper
• Repurposing Disulfiram (Tetraethylthiuram Disulfide) as a Potential Drug Candidate against Borrelia burgdorferi In Vitro and In Vivo

  2019cites this paper
• Integrating the drug, disulfiram into the vitamin E‐TPGS‐modified PEGylated nanostructured lipid carriers to synergize its repurposing for anti‐cancer therapy of solid tumors

  2019cites this paper
• Disulfiram inhibits placental soluble FMS-like tyrosine kinase-1 and soluble endoglin secretion independent of the proteasome.

  2018cites this paper
• Restrained management of copper level enhances the antineoplastic activity of imatinib in vitro and in vivo

  2018cites this paper
• Inhibition of histone lysine methyltransferases G9a and GLP by ejection of structural Zn(II).

  2018cites this paper
• Disulfiram with or without metformin inhibits oesophageal squamous cell carcinoma in vivo.

  2018cites this paper
• The Next Generation of Anticancer Metallopharmaceuticals: Cancer Stem Cell‐Active Inorganics

  2018cites this paper
• Time dependent of epigenetic effect of disulfiram on tumor suppressor gene of RASSF1A in Hela cancer cell line

  2018cites this paper
• Identification of Cancer Stem Cells: Applications for a Spy1 Clinical Trial

  2018cites this paper
• Disulfiram-loaded porous PLGA microparticle for inhibiting the proliferation and migration of non-small-cell lung cancer

  2017cites this paper
• Disulfiram is a slow-binding partial noncompetitive inhibitor of 20S proteasome activity.

  2017cites this paper
• Vaginal drug delivery for the localised treatment of cervical cancer

  2017cites this paper
• Recent Advances in Antabuse (Disulfiram): The Importance of its Metal-binding Ability to its Anticancer Activity.

  2017cites this paper
• Drug repurposing in cancer.

  2017cites this paper
• Disulfiram when Combined with Copper Enhances the Therapeutic Effects of Temozolomide for the Treatment of Glioblastoma

  2016cites this paper
• Disulfiram's Anticancer Activity: Evidence and Mechanisms.

  2016cites this paper
• Combining disulfiram and poly(l-glutamic acid)-cisplatin conjugates for combating cisplatin resistance.

  2016cites this paper
• Using an Old Drug to Target a New Drug Site: Application of Disulfiram to Target the Zn-Site in HCV NS5A Protein.

  2016cites this paper
• Univerzita Karlova v Praze 1. lékařská fakulta Autoreferát disertační práce Role of Islet 1, BDNF and nanoparticles in development, function and regeneration of the auditory system. Úloha Islet1, BDNF a nanočástic ve vývoji, funkci a regeneraci sluchového systému. MUDr

  2016cites this paper
• Stable loading and delivery of disulfiram with mPEG-PLGA/PCL mixed nanoparticles for tumor therapy.

  2016cites this paper
• Disulfiram and its novel derivative sensitize prostate cancer cells to the growth regulatory mechanisms of the cell by re‐expressing the epigenetically repressed tumor suppressor—estrogen receptor β

  2016cites this paper
• Disulfiram-induced cytotoxicity and endo-lysosomal sequestration of zinc in breast cancer cells

  2015cites this paper
• Antileishmanial Activity of Disulfiram and Thiuram Disulfide Analogs in an Ex Vivo Model System Is Selectively Enhanced by the Addition of Divalent Metal Ions

  2015cites this paper
• Breast Cancer Stem Cells & Therapy Resistance

  2015cites this paper
• Disulfiram‐loaded immediate and extended release vaginal tablets for the localised treatment of cervical cancer

  2015cites this paper
• The therapeutic potential of vaginal drug delivery in the treatment of cervical cancer.

  2015cites this paper
• A Copper-Mediated Disulfiram-Loaded pH-Triggered PEG-Shedding TAT Peptide-Modified Lipid Nanocapsules for Use in Tumor Therapy.

  2015cites this paper
• Investigation into the effects of zinc on the anti-breast cancer properties of disulfiram

  2015cites this paper
• Investigation of the anti-breast cancer efficacy and mechanisms of disulfiram

  2015cites this paper
• Disulfiram sensitizes pituitary adenoma cells to temozolomide by regulating O6-methylguanine-DNA methyltransferase expression.

  2015cites this paper
• DRUGS FOR CHRONIC ALCOHOLISM AND THEIR QUANTITATIVE ESTIMATION

  2015cites this paper
• Formulation and preparation of a stable intravenous disulfiram-loaded lipid emulsion

  2015cites this paper
• Properties of Stem Cells of Breast Cancer

  2015cites this paper
• Proteomic screening of molecular targets of crocin

  2014cites this paper
• Disulfiram is a direct and potent inhibitor of human O6-methylguanine-DNA methyltransferase (MGMT) in brain tumor cells and mouse brain and markedly increases the alkylating DNA damage.

  2014cites this paper
• Comparison of the anti-cancer effect of Disulfiram and 5-Aza-CdR on pancreatic cancer cell line PANC-1

  2014cites this paper
• Copper-zinc superoxide dismutase and glucose metabolism as redox targets for bortezomib resistance in multiple myeloma

  2014cites this paper
• Disulfiram and Copper Gluconate in Cancer Chemotherapy; a Review of the Literature

  2014cites this paper
• Multiple drug resistance due to resistance to stem cells and stem cell treatment progress in cancer (Review)

  2014cites this paper
• Effects of disulfiram on apoptosis in PANC-1 human pancreatic cancer cell line

  2014influential citation
• Development of disulfiram-loaded vaginal rings for the localised treatment of cervical cancer.

  2014cites this paper
• Inhibitory effect of Disulfiram/copper complex on non-small cell lung cancer cells.

  2014cites this paper
• Multi-targeted inhibition of tumor growth and lung metastasis by redox-sensitive shell crosslinked micelles loading disulfiram

  2014cites this paper
• The Proteasome-Ubiquitin System Is Required for Efficient Killing of Intracellular Streptococcus pneumoniae by Brain Endothelial Cells

  2014cites this paper
• Disulfiram/copper causes redox-related proteotoxicity and concomitant heat shock response in ovarian cancer cells that is augmented by auranofin-mediated thioredoxin inhibition

  2013cites this paper
• Degradation of NF-κB, p53 and other regulatory redox-sensitive proteins by thiol-conjugating and -nitrosylating drugs in human tumor cells.

  2013cites this paper
• For Peer Review Degradation of NF κB, p53 and other regulatory redox sensitive proteins by thiolconjugating andnitrosylating drugs in human tumor cells

  2013cites this paper
• A conceptually new treatment approach for relapsed glioblastoma: Coordinated undermining of survival paths with nine repurposed drugs (CUSP9) by the International Initiative for Accelerated Improvement of Glioblastoma Care

  2013cites this paper
• FORMULATION AND EVALUATION OF TETRAETHYLTHIURAM DISULPHIDE TABLETS BY AQUEOUS WET GRANULATION PROCESS

  2013cites this paper
• The Bca2 And Ampk Paradigm: Unraveling The Cancer Connection

  2013cites this paper
• and synergistically induce in prostate cells

  2013cites this paper
• Acidic pH of Tumor Microenvironment Enhances Cytotoxicity of the Disulfiram/Cu2+ Complex to Breast and Colon Cancer Cells

  2013cites this paper
• Disulfiram, an old drug with new potential therapeutic uses for human hematological malignancies

  2012influential citation
• Enhancement of cisplatin cytotoxicity by disulfiram involves activating transcription factor 3.

  2012cites this paper
• Minimally invasive drug delivery to the cochlea through application of nanoparticles to the round window membrane.

  2012cites this paper
• Chemical Biology Drug Sensitivity Screen Identifies Sunitinib as Synergistic Agent with Disulfiram in Prostate Cancer Cells

  2012cites this paper
• Dithiocarbamate-based coordination compounds as potent proteasome inhibitors in human cancer cells.

  2012cites this paper
• RNA-Seq of Human Breast Ductal Carcinoma In Situ Models Reveals Aldehyde Dehydrogenase Isoform 5A1 as a Novel Potential Target

  2012cites this paper
• Analysis of gene expression alterations in premalignant progression from normal mammary epithelium to ductal carcinoma in situ by multiple orthogonal tools

  2012cites this paper
• Chemical Biology Screen for Prostate Cancer Therapeutics

  2011cites this paper
• Phenotype-based drug screening in primary ovarian carcinoma cultures identifies intracellular iron depletion as a promising strategy for cancer treatment.

  2011cites this paper
• Proteasome inhibitor treatment in alcoholic liver disease.

  2011cites this paper
• High-Throughput Screening for Novel Prostate Cancer Drug Targets –Getting Personal

  2011cites this paper
• Disulfiram modulated ROS–MAPK and NFκB pathways and targeted breast cancer cells with cancer stem cell-like properties

  2011cites this paper
• Disulfiram, and disulfiram derivatives as novel potential anticancer drugs targeting the ubiquitin-proteasome system in both preclinical and clinical studies.

  2011cites this paper
• The disulfiram metabolites S-methyl-N,N-diethyldithiocarbamoyl sulfoxide and S-methyl-N,N-diethylthiocarbamoyl sulfone irreversibly inactivate betaine aldehyde dehydrogenase from Pseudomonas aeruginosa, both in vitro and in situ, and arrest bacterial growth.

  2011cites this paper
• Targeting malignancies with disulfiram (Antabuse): multidrug resistance, angiogenesis, and proteasome.

  2011cites this paper
• Disulfiram/copper complex activated JNK/c-jun pathway and sensitized cytotoxicity of doxorubicin in doxorubicin resistant leukemia HL60 cells.

  2011cites this paper
• Disulfiram is a DNA demethylating agent and inhibits prostate cancer cell growth

  2011cites this paper
• Gemcitabine response in pancreatic adenocarcinoma cells is synergistically enhanced by dithiocarbamate derivatives.

  2011cites this paper